CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 14, 2026

Total Value: $4.024M (100.0% shares, 0.0% debt)

Holdings (7)

GLD SPDR GOLD TR 81.5%

Value $3.28M Shares 7,623 Share Price $430.27 Est. Cost/Share $321.04 Unrealized @ Report Date —

BRK/B BERKSHIRE HATHAWAY INC DEL 8.7%

Value $348K Shares 727 Share Price $479.15 * Est. Cost/Share $411.72 Unrealized @ Report Date +19.9%

KYTX KYVERNA THERAPEUTICS INC 4.0%

Value $162K Shares 18,773 Share Price $8.63 * Est. Cost/Share $23.94 Unrealized @ Report Date -65.3%

LXEO LEXEO THERAPEUTICS INC 2.0%

Value $80,032 Shares 13,943 Share Price $5.74 * Est. Cost/Share $13.31 Unrealized @ Report Date -43.4%

XFOR X4 PHARMACEUTICALS INC 1.6%

Value $64,249 Shares 15,557 Share Price $4.13 * Est. Cost/Share $3.63 Unrealized @ Report Date +0.1%

IKT INHIBIKASE THERAPEUTICS INC 1.2%

Value $47,801 Shares 28,453 Share Price $1.68 * Est. Cost/Share $2.11 Unrealized @ Report Date -17.9%

ALXO ALX ONCOLOGY HLDGS INC 1.0%

Value $41,996 Shares 20,946 Share Price $2.00 * Est. Cost/Share $1.77 Unrealized @ Report Date 0.0%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
GLD	SPDR GOLD TR	7,623	$3.28M	81.5%	$430.27	$321.04	—	GOLD SHS	78463V107
BRK/B	BERKSHIRE HATHAWAY INC DEL	727	$348K	8.7%	$479.15 *	$411.72	+19.9%	CL B NEW	084670702
KYTX	KYVERNA THERAPEUTICS INC	18,773	$162K	4.0%	$8.63 *	$23.94	-65.3%	COM	501976104
LXEO	LEXEO THERAPEUTICS INC	13,943	$80,032	2.0%	$5.74 *	$13.31	-43.4%	COM	52886X107
XFOR	X4 PHARMACEUTICALS INC	15,557	$64,249	1.6%	$4.13 *	$3.63	+0.1%	COM NEW	98420X202
IKT	INHIBIKASE THERAPEUTICS INC	28,453	$47,801	1.2%	$1.68 *	$2.11	-17.9%	COM NEW	45719W205
ALXO	ALX ONCOLOGY HLDGS INC	20,946	$41,996	1.0%	$2.00 *	$1.77	0.0%	COM	00166B105